Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major
โ Scribed by Casey J. Brewer; Thomas D. Coates; John C. Wood
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 365 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Purpose
To evaluate the magnetic properties of the spleen in chronically transfused, ironโoverloaded patients with sickle cell disease (SCD) and thalassemia major (TM) and to compare splenic iron burdens to those in the liver, heart, pancreas, and kidneys.
Materials and Methods
A retrospective analysis of 63 TM and 46 SCD patients was performed. Spleen R2 and R2* values were calculated from spinโecho and gradientโecho images collected between April 2004 and September 2007.
Results
The spleen showed a different R2โR2* relationship than that previously established for the liver. At high iron concentrations (R2* > 300 Hz), spleen R2 was lower than predicted for liver. The proportion of splenic to hepatic iron content was greater in SCD patients compared with TM patients (23.8% vs. 13.8%). A weak association was found between splenic and liver ironโthis association was stronger in SCD patients. Little correlation was found between splenic iron and extrahepatic R2* values.
Conclusion
For spleen and liver tissue with the same R2* value, splenic R2 was significantly lower than hepatic R2, particularly for R2* > โ300 Hz. Splenic iron levels have little predictive value for R2* values of heart, pancreas, and kidney. J. Magn. Reson. Imaging 2009;29:357โ364. ยฉ 2009 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract Patients with sickle cell disease (SCD) appear to be at lower risk of endocrinopathies and cardiac dysfunction than those with thalassemia major (TM). Circulating redox active iron is lower in these patients, possibly due to increased systemic inflammation and circulating cytokines. Hep
## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (TxโSCD, __n__ = 199), and 64 nonโTxโSCD subjects to describe the frequency of ironโrelated morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si
Cardiac function was measured at rest and during exercise in 9 patients with sickle-cell anemia (SS) and coexisting homozygous alpha thalassemia-2 (alpha thal-2). Results were compared with 18 sickle cell patients with normal alpha globin genes, who were matched to the study group by age, gender, an